-+ 0.00%
-+ 0.00%
-+ 0.00%

Market news: Novo Nordisk announced the latest developments in the ZEUS phase III clinical trial, which targets patients with atherosclerotic cardiovascular disease, chronic kidney disease, and inflammation.

Zhitongcaijing·07/31/2026 11:25:13
Listen to the news
Market news: Novo Nordisk announced the latest developments in the ZEUS phase III clinical trial, which targets patients with atherosclerotic cardiovascular disease, chronic kidney disease, and inflammation.